Terns Pharmaceuticals, Inc. — Director's Dealing 2025

Feb 12, 2025

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Terns Pharmaceuticals, Inc. (TERN)
CIK: 0001831363
Period of Report: 2025-02-01

Reporting Person: Strauss David Eric (N/A)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	89673.00	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$17.00	2031-02-04	Common Stock (20000.00)		Direct
Stock Option (Right to Buy)	$10.72	2031-09-27	Common Stock (11250.00)		Direct
Stock Option (Right to Buy)	$10.43	2033-02-28	Common Stock (22500.00)		Direct
Stock Option (Right to Buy)	$7.20	2034-03-14	Common Stock (33750.00)		Direct
Stock Option (Right to Buy)	$6.59	2034-12-11	Common Stock (60000.00)		Direct

Footnotes

F1: Includes 2,892 shares represented by a Restricted Stock Unit ("RSU"), of which 25% of the original 11,570 shares subject to the RSUs vested on the first anniversary measured from January 1, 2022 (the "Vesting Commencement Date"), and 1/16th of the total number of shares vested or will vest quarterly thereafter, such that 100% of the RSUs will be fully vested on the fourth anniversary of the Vesting Commencement Date.

F2: Includes 15,750 shares represented by a Restricted Stock Unit ("RSU"), of which 25% of the original 31,500 shares subject to the RSUs vested on the first anniversary measured from January 1, 2023 (the "Vesting Commencement Date"), and 1/16th of the total number of shares vested or will vest quarterly thereafter, such that 100% of the RSUs will be fully vested on the fourth anniversary of the Vesting Commencement Date.

F3: Includes 12,675 shares represented by a Restricted Stock Unit ("RSU"), of which 25% of the original 16,900 shares subject to the RSUs vested on the first anniversary measured from January 1, 2024 (the "Vesting Commencement Date"), and 1/16th of the total number of shares vested or will vest quarterly thereafter, such that 100% of the RSUs will be fully vested on the fourth anniversary of the Vesting Commencement Date.

F4: 25% of the shares subject to the option vest on the first anniversary measured from January 25, 2021 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Vesting Commencement Date.

F5: 25% of the shares subject to the option vest on the first anniversary measured from September 28, 2021 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Vesting Commencement Date.

F6: 25% of the shares subject to the option vest on the first anniversary measured from January 1, 2023 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Vesting Commencement Date.

F7: 25% of the shares subject to the option vest on the first anniversary measured from January 1, 2024 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Vesting Commencement Date.

F8: 25% of the shares subject to the option vest on the first anniversary measured from December 12, 2024 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Vesting Commencement Date.